BioCryst Pharmaceuticals Inc
NASDAQ:BCRX

Watchlist Manager
BioCryst Pharmaceuticals Inc Logo
BioCryst Pharmaceuticals Inc
NASDAQ:BCRX
Watchlist
Price: 7.63 USD -0.13% Market Closed
Market Cap: 1.6B USD
Have any thoughts about
BioCryst Pharmaceuticals Inc?
Write Note

BioCryst Pharmaceuticals Inc
Net Income (Common)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

BioCryst Pharmaceuticals Inc
Net Income (Common) Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
BioCryst Pharmaceuticals Inc
NASDAQ:BCRX
Net Income (Common)
-$123.8m
CAGR 3-Years
18%
CAGR 5-Years
2%
CAGR 10-Years
-12%
Abbvie Inc
NYSE:ABBV
Net Income (Common)
$5.1B
CAGR 3-Years
-12%
CAGR 5-Years
9%
CAGR 10-Years
3%
Gilead Sciences Inc
NASDAQ:GILD
Net Income (Common)
$126m
CAGR 3-Years
-74%
CAGR 5-Years
-46%
CAGR 10-Years
-35%
Amgen Inc
NASDAQ:AMGN
Net Income (Common)
$4.2B
CAGR 3-Years
-9%
CAGR 5-Years
-12%
CAGR 10-Years
-1%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Net Income (Common)
-$479.8m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
1%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Net Income (Common)
$4.7B
CAGR 3-Years
-13%
CAGR 5-Years
17%
CAGR 10-Years
30%

See Also

What is BioCryst Pharmaceuticals Inc's Net Income (Common)?
Net Income (Common)
-123.8m USD

Based on the financial report for Sep 30, 2024, BioCryst Pharmaceuticals Inc's Net Income (Common) amounts to -123.8m USD.

What is BioCryst Pharmaceuticals Inc's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
-12%

Over the last year, the Net Income (Common) growth was 48%. The average annual Net Income (Common) growth rates for BioCryst Pharmaceuticals Inc have been 18% over the past three years , 2% over the past five years , and -12% over the past ten years .

Back to Top